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Abstract: Hip dysplasia, caused by both environmental and genetic components, is a common disorder characterized by hip instability in
humans and dogs. Unfortunately, the genetic mechanisms that cause the disease in both have not been fully determined. The aim of this
study was polymorphisms in the exon 2 and 3ʹ UTR regions of the CX3CR1 gene were determined and their effects on the development
of Canine Hip Dysplasia (CHD) in three dog breeds (German Shepherd, Belgian Malinois, Labrador Retriever). For this purpose,
a case -control study was designed with 172 dogs in Dog Breeding and Training Center (DBTC) in Turkey. Each dog was evaluated
according to the Norberg angle by the DBTC veterinarians. One hundred and seventeen dogs (32 German Shepherds, 49 Belgian
Malinois, 36 Labrador Retrievers) classified as normal were included in the control group, and fifty - five dogs (24 German Shepherds,
14 Belgian Malinois, 17 Labrador Retrievers) diagnosed with CHD were included in the case group. Molecular genetic analyzes were
performed with blood samples taken from each dog. Seven previously identified SNPs (g.8938599_8938600insCC, g.8937121G>A,
g.8937137A>G, g.8937319T>G, g.8937441T>C, g.8937450A>G, g.8937590C>T) and a rare novel deletion (g. 8937205_ 8937206del)
were identified in the 3ʹ UTR regions of the CX3CR1 gene. The distribution of SNPs alleles in the case and control was compared
by means of statistical analysis at allelic, genotypic, haplotypic, and SNP - SNP interaction levels. Single SNP analysis revealed that
g.8937121G>A was significantly associated with susceptibility to CHD in Belgian Malinois (p = 0.00049) in the codominant model. Five
SNP - SNP interactions were identified to be associated with CHD in Labrador Retrievers and the most suggestive of these was between
g.8938599_8938600insCC and g.8937450A>G (p = 0.0004). We found that one haplotype block, consisting of two SNPs (g.8937137A>G
and g.8937319T>G) was associated with susceptibility to CHD in Belgian Malinois (p = 0.022). None of the detected polymorphisms
was statistically significantly associated with CHD in German Shepherds.
Key words: CX3CR1, SNP, hip dysplasia, dog breeds

1. Introduction
Canine hip dysplasia (CHD) is the most prevalent
developmental orthopedic disease in dogs that causes pain,
functional limitation, and secondary osteoarthritis [1, 2].
CHD, a polygenic disorder with both environmental and
genetic components, is characterized by hip instability,
leading to hip laxity and often resulting in hip joint
degeneration, painful arthritis, and lameness [3, 4].
Compared to other breeds, large dog breeds are more
prone to CHD [5–7]. CHD is also common among
popular working and service dog breeds such as German
Shepherds, Belgian Malinois, and Labrador Retrievers
[8–11]. Working dogs trained for special tasks are widely
used for law enforcement and military services. Because
their lengthy training time is costly, illnesses and injuries
that could lead to early withdrawal from active duty are
carefully avoided. However, many working dog breeds

are retired before their planned retirement age due to
hereditary orthopedic diseases. The most common of
these are hip and elbow dysplasia [8]. In order to increase
both animal welfare and to prevent economic losses, many
countries have attempted to decrease the prevalence of
CHD, but the success expected from breeding programs
that are based on phenotypic selection against CHD has
not been achieved [12]. Today, it is thought that genetic
marker - assisted selection or genomic selection could be
more successful in breeding programs against CHD [12,
13].
Developmental dysplasia of the hip (DDH), which
shares pathways anatomical, biochemical, and clinical
features with CHD [2, 14], is a common problem that
causes serious impairment in the quality of life in humans.
CHD and DDH tend to develop osteoarthritis in the
affected joints, and both are treated in a similar manner [2,
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14, 15]. Moreover, environmental and genetic risk factors
are effective in CHD and DDH formation. Over the last
years, many studies have been carried out to identify the
genetic background of hip dysplasia in both humans and
dogs [5, 6, 16-24]. Approximately 30 genes have been
reported in association with DDH [24], while over 50
have been reported in association with CHD [5, 6, 16–
23]. However, very few of these have been confirmed in
different populations, and none of them have been firmly
correlated with hip dysplasia [13, 24].
Considering that more than 350 diseases that are often
caused by the same pathways and genes are analogous in
dogs and humans, co - studies with both species to detect
genetic markers associated with hip dysplasia can provide
important data on the genetic background of the disease.
For this purpose, the relationship between the C-X3-C
motif chemokine receptor 1 (CX3CR1) gene, which
has been reported to be associated with hip dysplasia in
humans, with CHD was investigated in three purebred
dog breeds (Labrador Retriever, Belgian Malinois, and
German Shepherd). The association with the CX3CR1
gene to DDH has been confirmed in three independent
studies [25–27]. CX3CR1 is known to play a role in bone
homeostasis and chondrocyte proliferation. It encodes
a receptor of chemokine CX3CL1, which includes a
G ‐ protein coupled transmembrane domain [25]. The
CX3CR1 gene (ENSCAFG00000031104), located on
chromosome 23 in dogs, has 2 exons (exon 1: 77 bp, exon
2: 1101 bp) and encodes 384 amino acid residues (https://
www.ensembl.org/index.html).
The CX3CR1 is an interesting target for joint disorders.
Polymorphisms on the CX3CR1 gene are thought to modify
the biological role of CX3CL1 and may cause many joint
diseases [28]. In addition, polymorphisms in the CX3CR1
gene have been reported to increase susceptibility to hip
dysplasia in humans [25, 26]. Therefore, the CX3CR1
gene was chosen as the target in this research. The goal
of the present study was to investigate the relationship
between the SNPs in the CX3CR1 gene and CHD disease
in three purebred dog breeds (German Shepherd, Belgian
Malinois, Labrador Retriever). For that purpose, genetic
variations in the exon 2 and 3ꞌ UTR regions (3054 bp) of
the CX3CR1 gene were investigated by DNA sequence
analysis. Associations of the detected SNPs with the
disease were analyzed using single - locus analysis, two dimensional SNP analysis (interaction), and haplotype based approaches.
2. Materials and methods
2.1. Sample collection
Permission was obtained from Trakya University Animal
Experiments Local Ethics Committee to collect blood
samples from dogs. For two years (2018–2019), a total

of 172 blood samples were collected that purebred dogs
(56 German Shepherds, 63 Belgian Malinois, 53 Labrador
Retrievers) raised in Dog Breeding and Training Center
(DBTC) in Turkey. Norberg angles were measured in
ventrodorsal hip - extended radiographic views by the
DBTC veterinarians. The radiological analyses were
performed in the veterinary clinic in the DBTC. One
hundred and seventy - two purebred dogs were divided
into two groups as the case (< 105, with CHD) and the
control (≥ 105, normal) according to Norberg angles. Fifty
-five purebred dogs were classified as the case (24 German
Shepherds, 14 Belgian Malinois, 17 Labrador Retrievers)
and 117 purebred dogs as the control (32 German
Shepherds, 49 Belgian Malinois, 36 Labrador Retrievers).
The case group consisted of one - year - old dogs diagnosed
with CHD and the control group consisted of dogs older
than one-year old that have normal hip joints. For the
case group and the control group, blood samples were
collected in EDTA - tubes and stored at –18 ℃ in a deep
freezer until molecular studies were performed. All cases
and controls were selected to be unrelated at the parental
level. The privacy rights of DBTC were maintained. The
environmental impact factors were eliminated because
of dogs included in the study were in similar feeding and
sheltering conditions.
2.2 Genotyping
Genomic DNA was extracted from the blood samples using
the Quick Blood DNA Purification Kit (Eurx, Poland)
according to the manufacturer’s instructions. Five primer
pairs were designed based on ENSCAFG00000031104
to amplify exon 2 and 3ꞌ UTR regions in the CX3CR1
gene using the Primer 3 program (https://www.ncbi.
nlm.nih.gov/tools/primer-blast/).
The
information
for oligonucleotide primers, PCR product sizes, and
annealing temperatures are shown in Table 1. PCR
amplifications were carried out in volumes of 25 µL using;
12.5 µL PCR 2X Master Mix (Thermo Fisher Scientific,
USA, cat no. K0171), 50 ng genomic DNA, 5 pmol each
primer, and ddH2O. The temperature cycling protocol on
T100 Thermal Cycler (Biorad, USA) consisted of 3 min
incubation at 95 ℃ followed by 35 cycles at 95 ℃ for 30
sec, annealing for 30 sec (annealing temperatures for each
primer pairs are given in Table 1) 72 ℃ for 45 sec, and
a final extension at 72 ℃ for 10 min. Five microliters of
the PCR products were subjected to electrophoresis on
2% agarose gel (Bioshop, Canada) and then visualized by
the WGD30S Molecular Imager (Wisd, USA). The PCR
products were purified using the GeneMatrix (EURx, cat
no. E3520 - 02) in accordance with the manufacturer’s
protocol. The purified PCR products were sequenced in
the forward direction of the primers in Table 1. To confirm
the results, bidirectional DNA sequencing was performed
with randomly selected samples from each genotype.
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Table 1. Primer names, sequences, annealing temperatures, PCR product sizes, and primer locations in the CX3CR1 gene.
Primer
name
CX1
CX2
CX3
CX4
CX5

Primer sequence (5ʹ > 3ʹ)
F:TACAGGAAAACAGTGTCCGC
R:TGTGGGACCAAATAGAATCCCAA
F:GTTGTTTTTGGGCATTCGGTT
R:CTGCTCCCCCTGCTCATTAT
F:AGGTTGGTGGGCATCTCTTG
R:TACCAAAGCCTTGTCCCCAC
F:GCTCTGTCAACACTGCTCCT
R:CAAGAGATGCCCACCAACCT
F:CCAGAGGATATCATTGAAGAGGAG
R:CTGACCAAGCCCTCCAGTTG

Amplification
region*

Location

Annealing
Temperature (℃)

PCR Product
(bp)

8939331-8940080

Exon2

60

750

8938803-8939394

Exon 2

60

592

8938293-8938921

3ʹ UTR

66

629

8937757-8938312

3ʹ UTR

60

556

8937026-8937658

3ʹ UTR

62

663

* The location on the reference genome accession ID: NC_006605.3. bp; base pair.

Sequencing reactions were performed by using the DTCS
- Quick Start Sequencing Kit and T100 Thermal Cycler
(Biorad, USA) with the following program: 96 °C for 20
s, 50°C for 60 s, 60°C for 4 min for 40 cycles. Sequencing
was performed by using the GenomeLab GeXP Genetic
Analysis System (Beckman Coulter, USA). The sequences
were analyzed using the BioEdit v7.0.5.3 software [29] and
Chromas v2.6.6 (http://www.technelysium.com.au).
2.3. Statistical analyses
Hardy Weinberg equilibrium (HWE) P - values for
each SNP were calculated for each dog breed using the
HardyWeinberg-1.6.3 [30] package with R Software
version 3.6.2 [31]. HWE in control groups was assessed
using Pearson chi - squared test or Fisher exact test when
necessary.
The genetic data were analyzed using single - locus
analysis, two - dimensional SNP interaction analysis, and
haplotype - based approaches. The associations between
the single -SNPs and the risk of CHD were evaluated by
calculating the odds ratios (OR) with 95% conﬁdence
intervals (CI) using SNPassoc under codominant genetic
models. These analyses were performed by the SNPassoc
package [32] in R software –3.6.2 [31] and SPSS (Version
20.0, Chicago, IC, USA). Differences were considered
statistically significant when P - value was less than 0.05.
Bonferroni corrections were applied for all multiple tests.
Linkage disequilibrium (LD) and haplotype
frequencies, as well as an association between haplotype
and CHD, were determined with the Haploview [33]
software. Haplotypes were analyzed within blocks defined
by the default confidence - interval method according to
the criteria defined by Gabriel et al. [34]. The protocol by
default ignores markers with minor allele frequency below
0.05. This method sorts the list of all possible blocks, and
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after starting with the largest one and keep adding blocks as
long as they do not overlap with an already declared block.
Potential interactions between pairs of variants on
CHD were estimated using the SNPassoc package within R
statistical software performing log - likelihood ratio tests.
The microRNA (miRNA) target sites on the CX3CR1 gene
were predicted using the online miRDB program (www.
mirdb.org).
3. Results
The DNA samples from three different dog breeds (Belgian
Malinois, Labrador Retrievers, German Shepherds) were
amplified (Figure 1) and sequenced for the exon 2 and
3ꞌ UTR in the CX3CR1 gene. Eight variations (6 SNPs,
1 insertion, 1 deletion) were identified by sequencing
analysis of the 3ꞌ UTR region. There was no polymorphism
in the exon 2 region. Seven variations detected in each of
three dog breeds have been previously described in the
dbSNP, Ensemble (https://www.ensembl.org/index.html).
However, the g.8937205_8937206del was not found in the
dbSNP. The rare novel deletion (g.8937205_8937206del)
was identified only in Belgian Malinois. Three genotypes
of g.8938599_8938600insCC were observed in Belgian
Malinois, but CC/CC homozygote genotype was not found
in Labrador Retriever and German Shepherd. The AA
genotype of g.8937121G>A SNP was not found in all three
purebred dog breeds. Three genotypes of g.8937319T>G
were detected in Labrador Retrievers, while the GG
genotype was not observed in Belgian Malinois and TG
genotype in German Shepherd. The GA genotype of
g.8937137A>G SNP was only found in Belgian Malinois,
but other genotypes (AA and GG) were observed in all three
dog breeds. The TT and CC genotypes of g.8937590C>T
SNP were observed in all three dog breeds but CT genotype
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Figure 1. A- Agarose gel electrophoresis results of PCR products. M; marker (100-1000 bp). B- Graph of the
CX3CR1 gene and position of amplified DNA fragments on the gene C- The electropherogram of DNA sequencing
(forward strand) showing the AA deletion (g. 8937205_ 8937206del) in the 3ʹ UTR region of the CX3CR1 gene.
D- The AA deletion was confirmed using DNA sequencing the reverse strand.

was not only found in German Shepherd (Table 2). Six of
the seven SNPs detected in German Shepherd dogs were
observed to deviate from HWE for the control group. In
the German Shepherd, only one SNP (g.8937121G>A)
was found to be in HWE for the control group. Two SNPs
were found to deviate from HWE for the control group
in Belgian Malinois (g.8937441T>C, g.8937590C>T)
and Labrador Retriever (g.8937137A>G, g.8937590C>T)
(Table 3). Details of all variants are presented in Table 2.
3.1. Single - marker association analysis
The distribution of allele and genotype frequencies of
polymorphisms determined in the CX3CR1 gene in three
dog breeds are shown in Table 3. Statistical correlation
analysis was not performed on polymorphisms deviating
from HWE in the control groups. No statistically significant
association was observed between polymorphisms and
CHD in Labrador Retrievers and German Shepherds (Table

3). However, two SNPs (g.8937121G>A, g.8937137A>G)
were found to be associated (p < 0.001 and p < 0.05)
with CHD in Belgian Malinois (Table 4). One of them,
g.8937121G>A, was statistically significant after applying
the Bonferroni correction for the eight SNPs. Statistical
significance level was determined as p < 0.00625 after
Bonferroni correction for multiple tests.
g.8937137A>G, a weak association was observed in
both genotype and allele distributions between CHD and
control groups (p = 0.046 for genotype distribution and
0.01 for allele distribution). Compared to the AA genotype,
the AG and GG genotypes were significantly correlated
with a reduced risk of CHD (OR = 0.108; 95% CI = 0.017–
0.695 for AG genotype, OR = 0.100; 95% CI = 0.010–0.975
for AA genotype). Carriers of the G allele had a 3.333– fold
higher risk of developing CHD than those with the A allele
(OR = 3.333, 95% CI = 1.279 –8.688) (Table 4).
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Table 2. Information of eight SNPs identified in the CX3CR1 gene and genotype frequencies of the three dog breeds.

SNP name

GenBank
no.

Gene
region

g.8938599_8938600insCC rs851814810 3ꞌ UTR
g.8937121G>A

rs9022770

3ꞌ UTR

g.8937137A>G

rs9022769

3ꞌ UTR

g. 8937205_ 8937206del

*

3ꞌ UTR

g.8937319T>G

rs852431030 3ꞌ UTR

g.8937441T>C

rs852569240 3ꞌ UTR

g.8937450A>G
g.8937590C>T

rs851634517 3ꞌ UTR
rs853018978 3ꞌ UTR

Belgian Malinois
(n = 63) Genotype /
Frequencies

Labrador Retriever
(n = 53) Genotype /
Frequencies

German Shepherd
(n = 56) Genotype /
Frequencies

--/--

--/CC

CC/CC --/--

--/CC

CC/CC --/--

--/CC

CC/CC

0.540

0.381

0.079

0.642

0.358

0.000

0.982

0.018

0.000

GG

GA

AA

GG

GA

AA

GG

GA

AA

0.873

0.127

0.000

0.755

0.245

0.000

0.857

0.143

0.000

GG

GA

AA

GG

GA

AA

GG

GA

AA

0.095

0.190

0.714

0.679

0.000

0.321

0.018

0.000

0.982

AA/AA AA/-- --/--

Monomorphic

Monomorphic

0.889

0.111

0.000

TT

TG

GG

TT

TG

GG

TT

TG

GG

0.730

0.270

0.000

0.396

0.434

0.170

0.982

0.000

0.018

TT

TC

CC

TT

TC

CC

TT

TC

CC

0.603

0.238

0.159

0.075

0.528

0.396

0.964

0.018

0.018

AA

AG

GG

AA

AG

GG

AA

AG

GG

0.587

0.397

0.016

0.075

0.604

0.321

0.964

0.018

0.018

TT

CT

CC

TT

CT

CC

TT

CT

CC

0.762

0.190

0.048

0.642

0.189

0.170

0.982

0.000

0.018

* It was not found in dbSNP.

g.8937121G>A was found to be more correlated with
the CHD both allelic and genotypic levels (respectively,
p = 0.002, p = 0.00049) than g.8937137A>G (Table 4).
AA genotype could not be determined in the control and
case groups. However, a higher risk of CHD was found in
carriers of the GA genotype compared to carriers of the
GG genotype (OR = 17.625, 95% CI = 3.011–103.181).
In addition, evaluation of allele frequencies revealed that
carriers of the A allele had a 13.091 - fold higher risk of
developing CHD than those with the G allele (OR =
13.091, 95% CI = 2.474–69.264).
3.2. SNPs on miRNA target regions
miRNA binding prediction analysis of the 3ʹ UTR region of
the CX3CR1 gene was performed using the miRDB (www.
mirdb.org) that online miRNA database. Eight miRNA
was predicted to be targeted CX3CR1 gene in dogs. These
miRNAs have a target score in the range of 54 - 86 (Table
5). It was determined an SNP (g.8937590C>T) creates
(C allele) or destroys (T allele) miRNA (cfa-miR-488)
seed region (Figure 2). C allele creates a 7mer - A1 target
site sequence for the cfa-miR-488. Interestingly, control
groups of all three dog breeds deviated from the HWE for
this SNP, therefore marker - association analysis could not
be performed for this SNP.
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3.3. Haplotype - based association study
The extent of linkage disequilibrium (LD) between the
six identified SNPs was estimated separately for all three
dog breeds using Haploview 4.2. Because SNPs detected
in German Shepherds did not meet the data quality
criteria applied by the Haploview program, no further
analyses were performed. In Belgian Malinois, the two
SNPs (g.8937137A>G, g.8937319T>G) were found highly
linked in one haplotype block with D´= 1 (Figure 3). The
haplotype block was consisted of three haplotypes, AT,
GG, and GT, with frequencies of 0.810, 0.135, and 0.056,
respectively. Compared with the AT, the GT haplotype had
a significantly higher frequency in the case group than in
the control group, indicating it could significantly increase
the susceptibility to CHD in Belgian Malinois (p = 0.022,
OR = 6.222, 95% CI = 1.280–30.243) (Table 6). These
P - values did not remain significant after Bonferroni
correction for the eight SNPs.
Two SNPs deviating from HWE in Labrador Retrievers
were excluded from the analysis by the HaploView
program. The three SNPs (g.8937319T>G, rs8522569240,
g.8937450A>G) in the CX3CR1 gene in Labrador
Retrievers formed one LD block. GGG, TAA, TGG and
TGA haplotypes had frequencies 0.387, 0.340, 0.236, and
0.038, respectively. Haplotypes were not significantly

--/CC

--/--

g.8937441T>C

g.8937319T>G

g. 8937205_ 8937206del

g.8937137A>G

g.8937121G>A

0.21

0.43 (n = 6)

0.57 (n = 8)

G

TT

TC

0.29

0.79

T

C

0.00

GG

0.71

0.43 (n = 6)

TG

0.00

0.57 (n = 8)

TT

T

0.07

--

CC

0.93

0.14 (n = 2)

AA/--

0.00

0.86 (n =12)

AA/AA

AA

0.64

A

--/--

0.36

0.14 (n = 2)

GA

G

0.29 (n = 4)

GG

0.57 (n = 8)

0.21

AA

0.79

A

0.43 (n = 6)

GA

G

0.57 (n = 8)

GG

0.00

0.18

CC

AA

0.82

0.28

0.72

0.20 (n = 10)

0.15 (n = 7)

0.65 (n = 32)

0.11

0.89

0.00

0.22 (n = 11)

0.78 (n = 38)

0.05

0.95

0.00

0.10 (n = 5)

0.90 (n = 44)

0.86

0.14

0.76 (n = 37)

0.20 (n = 10)

0.04 (n = 2)

0.02

0.98

0.00

0.04 (n = 2)

0.96 (n = 47)

0.30

0.70

0.10 (n = 5)

0.39 (n = 19)

0.36 (n = 5)

0.00

0.51 (n = 25)

Control
(n = 49)

0.64 (n = 9)

Case
(n =14)

Belgian Malinois

--

g.8938599_8938600insCC CC/CC

SNP code

Genotype
allele

< 0.001

1.00

1.00

0.232

1.00

0.730

Control
HWE
p value

**

0.142

0.676

0.046

0.0005

0.537

CA
P value

0.62

0.38

0.35 (n = 6)

0.53 (n = 9)

0.12 (n = 2)

0.38

0.62

0.12 (n = 2)

0.53 (n = 9)

0.35 (n = 6)

0.00

1.00

0.00

0.00

1.00 (n = 17)

0.24

0.76

0.24 (n = 4)

0.00

0.76 (n = 13)

0.15

0.85

0.00

0.12 (n = 2)

0.88 (n = 15)

0.26

0.74

0.00

0.53 (n = 9)

0.47 (n = 8)

Case
(n =17)

0.68

0.32

0.41 (n = 15)

0.53 (n = 19)

0.06 (n = 2)

0.39

0.61

0.19 (n = 7)

0.39 (n = 14)

0.42 (n = 15)

0.00

1.00

0.00

0.00

1.00 (n = 36)

0.36

0.64

0.36 (n = 13)

0.00

0.64 (n = 23)

0.04

0.96

0.00

0.31 (n = 11)

0.69 (n = 25)

0.14

0.86

0.00

0.28 (n = 10)

0.72 (n = 26)

Control
(n = 36)

Labrador Retriever

0.276

0.275

*

< 0.001

0.569

1.00

Control
HWE
p value

Table 3. Genotype and allele frequencies of the SNPs in the CX3CR1 gene, P values for HWE and correlation analyses.

0.715

0.589

**

**

0.120

0.077

CA
p value

0.00

1.00

0.00

0.00

1.00 (n = 24)

0.00

1.00

0.00

0.00

1.00 (n = 24)

0.00

1.00

0.00

0.00

1.00 (n = 24)

1.00

0.00

1.00 (n = 24)

0.00

0.00

0.04

0.96

0.00

0.08 (n = 2)

0.92 (n = 22)

0.02

0.98

0.00

0.05 (n = 1)

0.95 (n = 23)

Case
(n = 4)

0.05

0.95

0.03 (n = 1)

0.03 (n = 1)

0.94 (n = 30)

0.03

0.97

0.03 (n = 1)

0.00

0.97 (n = 31)

0.00

1.00

0.00

0.00

1.00 (n = 32)

0.97

0.03

0.97 (n = 31)

0.00

0.03 (n = 1)

0.09

0.91

0.81 (n = 26)
0.19
(n = 6)
0.00

0.00

1.00

0.00

0.00

1.00 (n = 32)

Control
(n = 32)

German Shepherd

0.046

0.016

*

0.016

1.00

0.000

Control
HWE
p value

**

**

**

**

0.258

**

CA
p value
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80

0.00

0.71

0.29

0.64 (n = 9)

0.36 (n = 5)

0.00

0.82

0.18

A

G

TT

CT

CC

T

C

0.57 (n = 8)

AG

GG

0.43 (n = 6)

AA

0.13

0.87

0.06 (n = 3)

0.14 (n = 7)

0.80 (n = 39)

0.19

0.81

0.02 (n = 1)

0.35 (n = 17)

0.63 (n = 31)

0.025

0.666

**

0.390

0.32

0.68

0.12 (n = 2)

0.41 (n = 7)

0.47 (n = 8)

0.56

0.44

0.24 (n = 4)

0.64 (n = 11)

0.12 (n = 2)

0.24

0.76

0.19 (n = 7)

0.09 (n = 3)

0.72 (n = 26)

0.65

0.35

0.36 (n = 13)

0.58 (n = 21)

0.06 (n = 2)

< 0.001

0.145

**

0.541

0.00

1.00

0.00

0.00

1.00 (n = 24)

0.00

1.00

0.00

0.00

1.00 (n = 24)

0.03

0.97

0.03 (n = 1)

0.00

0.97 (n = 31)

0.05

0.95

0.03 (n = 1)

0.03 (n = 1)

0.94 (n = 30)

0.016

0.046

**

**

*Monomorphic ** Statistical correlation analysis was not performed because it deviated from the Hardy Weinberg Equilibrium (HWE) or monomorphic. CA; Correlation Analysis.

g.8937590C>T

g.8937450A>G

Table 3. (Continued).
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Table 4. Allelic and genotypic association of the SNPs with CHD in Belgian Malinois.
SNP / Genotypes /
Alleles

Case

Control

GG

8

47

GA

6

2

AA

0

0

G

22

96

A

6

2

GG

4

2

AG

2

10

AA

8

37

G

10

14

A

18

84

p value

OR

95% CI

1

-

17.625

3.011 - 103.181

-

-

13.091

2.474 - 69.264

1

-

0.108

0.017 - 0.695

0.100

0.010 - 0.975

3.333

1.279 - 8.688

g.8937121G>A
0.00049

0.002

g.8937137A>G
0.046

0.011

OR: odds ratio, 95% CI: 95% confidence interval.
Table 5. miRNAs and target seed location in 3ʹ UTR in the CX3CR1 gene.
miRNA code

Target score
miRNA sequence (5ʹ-3ʹ)

Seed location
in 3ʹ UTR

cfa-miR-8899

86

GUUGGGGUCCAUGCGUCUAGGAC

722; 841

cfa-miR-8836

83

AGGAAAGGAGAAGGGCCACA

825; 1053; 1125; 1300

cfa-miR-1837

73

UCUCAGAGGGACUGCGACAUCU

350; 367; 764

cfa-miR-8843

71

UUGUUUUUUUCUCUCGCCCCGCCUG

116; 1460

cfa-miR-589

64

UGAGAACCAUGUCUGAUCAGAG

1630

cfa-miR-488

58

CCCAGAUAAUGGCACUCUCAA

1104; 1332

cfa-miR-7180

57

CUGUGGCCUCUGGGUGUGUACCCU

1620

cfa-miR-8883

54

UCUGGGUGAGGAUUCGCAGGACUUU

741; 1528

miRNA: microRNA

associated with CHD after performing association analyses
by the HaploView (Table 6).
3.4. Two dimensional SNP associate analysis
Two-dimensional analysis of variant pairs interactions
was performed using the codominant model. Although
significant interaction was not observed in both German
Shepherds and Belgian Malinois (data not shown), five
significant interactions were identified in Labrador
Retrievers (Figure 4). It was found statistically significant
interactions between g.8938599_8938600insCC with
each of the five SNPs (g.8937590C>T, g.8937450A>G,
g.8937441T>C,
g.8937319T>G,
g.8937137A>G).
However, after applying Bonferroni correction for all
possible combinations (n = 64, p < 0.00078) one of them

remained significant (g.8938599_8938600insCC and
g.8937450A>G, p = 0.00048). Other p - values were shown
in Figure 4.
4. Discussion
Although CHD was first reported to originate from
inbreeding 70 years ago [35], its etiology has not been fully
elucidated in studies conducted so far. However, a great
number of SNPs have been reported to be susceptible or
protective for CHD and DDH [1, 5, 6, 17-21, 36-39]. Many
human and canine diseases are thought to have the same
causes and similar genetic mechanisms. Previous studies
have identified variants of the CX3CR1 gene underlying hip
dysplasia in humans. CX3CL1 and its receptor CX3CR1 are
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1

1

Figure 2. The binding site of the cfa-miR-488 and the CX3CR1 gene was predicted
by miRDB. C allele of the g.8937590C>T creates a target region for the cfa-miR-488.

Figure 3. Linkage disequilibrium plot. A- Regions with high D’ values are dark red, and regions with low D’ values
are lighter shades of red. Red diamond without a number corresponds to D’ values of 1.0. B- Black represents high
LD (r2 = 1) and white indicates the absence of correlation (r2 = 0).

interesting targets for joint disorders. Polymorphisms on
the CX3CR1 gene are thought to modify the biological role
of CX3CL1 and may cause many joint diseases [28]. The
CX3CL1 / CX3CR1 axis is involved in the differentiation
of mesenchymal stem cells into chondrocytes and the
maturation of osteoclast cells, which are responsible for the
destruction of bone tissue. In mesenchymal stem cells that
will differentiate into chondrocyte cells, the CX3CR1 gene
is known to be expressed at high levels [40, 41]. Therefore,
it is thought that the false expression of the gene will cause
the problematic development of acetabular cartilage,
which may be the cause of future joint disorders [26].
The two SNPs (rs3732378, rs3732379) reported to be
associated with the development of hip dysplasia in humans
are located in the exon 2 region of the CX3CR1 gene [25,
26]. Both of these polymorphisms are the missense that
leads to amino acid substitutions (T280M for rs3732378
and V249I for rs3732379) in the transmembrane domain
of the CX3CR1 protein [26]. However, genetic variation
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was not detected in the exon 2 region of the dog breeds
used in the present study. According to NCBI, there are 326
reference SNPs in the exon 2 region of the human CX3CR1
gene and one reference SNP (rs851299957, synonymous
variant) in the same region in dogs according to Ensembl.
Given that the minor allele frequencies of diseases-causing
SNPs are generally low, new variations may be found in the
exon 2 region by working with larger populations.
In the present study, six SNPs, a deletion, and an
insertion in 3ʹ UTR regions of the CX3CR1 gene were
determined. The novel deletion (g. 8937205_8937206del)
was only detected in Belgian Malinois (Table 2). The
minor allele frequency of the deletion was 0.05 in the
control group and 0.07 in the case group. The number of
SNPs deviating from HWE was found to be 6, 2, and 2 for
control groups in German Shepherd, Belgian Malinois, and
Labrador Retriever, respectively. An SNP (g.8937121G>A)
was found to be in HWE for control groups in all three dog
breeds (Table 3).
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Table 6. Haplotypes in Belgian Malinois and Labrador Retriever.
Breed
Belgian
Malinois

Labrador
Retriever

Haplotypes

Total
frequencies

Case
frequencies

Control
frequencies

p
value

OR

95% CI

A

T

0.810

0.643

0.857

0.011

1

-

G

G

0.135

0.214

0.112

0.163

-

-

G

T

0.056

0.143

0.031

0.022

6.222

1.280 - 30.243

G

G

G

0.387

0.382

0.389

0.949

-

-

T

A

A

0.340

0.382

0.319

0.523

-

-

T

G

G

0.236

0.176

0.264

0.322

-

-

T

G

A

0.038

0.059

0.028

0.434

-

-

OR: odds ratio, 95% CI: 95% confidence interval.

1

Figure 4. SNP - SNP interactions plot in Labrador Retriever dogs. The plot shows the significance levels of SNP - SNP interactions
and CHD in the codominant model. Each small square represents the p-values obtained from different likelihood ratio tests. Different
gradient colors indicate different statistical significance levels (the darker shades represent smaller, more significant p-values). Along
the diagonal, as indicated by a line, are the p-values of the single SNP tests. The upper triangle in the matrix contains the p-values for
the interaction (epistasis) log - likelihood ratio test. the lower triangle contains the p-values from the likelihood ratio test comparing
the two - SNP additive likelihood to the best of the single - SNP models. p-value of interactions: p1 = 0.003, p2 = 0.013, p3 = 0.001, p4 =
0.0004, p5 = 0.014

As a result of single SNP association analysis, the G
allele of the g.8937137A>G and A allele of g.8937121G>A
were found to increase susceptibility to CHD in Belgian
Malinois (Table 3). It was observed that the statistical
correlation of g.8937137A>G (OR = 3.333, 95% CI =

1.279 - 8.688) with CHD was weaker than g.8937121G>A
(OR = 17.625, 95% CI = 3.011 - 103.181) (Table 4). The
g.8937121G>A was statistically significant after applying
the Bonferroni correction for the eight SNPs. In previous
studies, it has been reported that SNPs in genes involved
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in the pathways that regulate bone - cartilage development
and homeostasis are associated with CHD [1, 17, 19, 38].
The two intronic SNPs in the CTIF (rs24413139 G>A) and
TSPAN4 genes (rs22634232 G>T) have been reported to
be associated with CHD in the Belgian Malinois and the
Labrador Retriever [38]. In addition, a downstream gene
variant (MMRN2 gene, rs24111003 C>T) has been found
to be associated with CHD [38]. The two SNPs in the 5ʹ UTR
and 3ʹ UTR region of the CHST3 gene have been reported
to be associated with the development of CHD in Labrador
Retrievers [1]. It has been reported to be associated with
two intergenic (BICF2S2367279, BICF2P1086886) and
the one intronic SNPs (BICF2P281364, KSR2 gene) the
development of CHD in German Shepherd [17].
miRNAs play critical roles in chondrocyte proliferation,
differentiation, apoptosis, and endochondral ossification
[42-45]. In addition, miRNAs control the activity of many
genes required for bone metabolism [46]. Abnormal
miRNA expression has been reported to play a role in
many diseases, including hip dysplasia, osteoarthritis,
and osteoporosis [43, 47-49]. In the present research, the
potential effects of SNPs in miRNA binding sites in the
CX3CR1 gene were investigated in silico using miRDB.
Eight miRNAs binding sites were determined in the 3ʹ
UTR regions of the CX3CR1 gene (Table 5). An SNP
(g.8937590C>T) was identified in the core binding site of
the cfa-miR-488 (Figure 2). The T allele of g.8937590C>T
destroys the core binding site and can cause the CX3CR1
gene overexpression by abolishing control of gene
expression. In addition, miR-488 has been reported to play
a role in chondrocyte differentiation, regulation osteoblast
function, bone formation, and cartilage development [5052]. Because the control groups deviated from the HWE in
all three dog breeds for g.8937590C>T, a single - marker
associated analysis was not performed. However, when the
SNP - SNP interaction was evaluated, it was found that an
interaction g.8937590C>T with g.8938599_8938600insCC
in Labrador Retrievers was significantly correlated (p =
0.014) with the development of CHD. This correlation may
be due to changes in the expression status of the CXCR1
gene. It is known that non - coding disease - associated
SNPs within 3ʹ UTR regions of the genes can result in gene
dysregulation at the posttranscriptional level [53].
The extent of LD between the identified SNPs was
estimated in Belgian Malinois and Labrador Retriever.
In Belgian Malinois, the two SNPs (g.8937137A>G,
g.8937319T>G) were found highly linked in one haplotype
block with D´= 1 (Figure 3). The haplotype block was
consist of three haplotypes, AT, GG, and GT in Belgian
Malinois. Haplotype GT increased susceptibility (p =
0.022, OR = 6.222, 95% CI = 1.280 - 30.243) to CHD
disease in Belgian Malinois (Table 6). These P - values did
not remain significant after the Bonferroni correction for
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the eight SNPs. In the Labrador Retriever, the three SNPs
(g.8937319T>G, rs8522569240, g.8937450A>G) formed
one LD block. GGG, TAA, TGG and TGA haplotypes
had frequencies 0.387, 0.340, 0.236 and 0.038, respectively
(Table 6). Haplotypes were not significantly associated
with CHD after performing association analyses by the
HaploView in Labrador Retriever.
Although individual SNPs are popular markers
for determining susceptibility to diseases, SNP - SNP
interactions help to understand the complex mechanisms
underlying diseases. An SNP, which does not affect disease
formation alone, can interact with different SNPs and have
a strong effect on disease formation [54–56]. In the present
study, interactions of SNPs detected at the 3ʹ UTR region
of the CX3CR1 gene were found to be associated with the
development of CHD in Labrador Retrievers (p < 0.001).
It was determined that the interaction of the CC insertion
(g.8938599_8938600insCC) with 5 SNPs (Figure 4) had
statistically significant effects with CHD development
in Labrador Retrievers. However, after the Bonferroni
correction one of them remained statistically significant
(g.8938599_8938600insCC and g.8937450A>G, p =
0.00048). No statistically significant correlation was found
between SNP - SNP interaction and CHD in Belgian
Malinois and German Shepherd (P > 0.05). These results
support the opinion that alternative genetic factors
associated with the development of CHD may play a role
in different breeds or even populations [18].
Until recently, more than 200 marker candidates
associated with CHD have been proposed in genomewide association studies [1, 5, 6, 17-21, 36-39]. Only one
of them is in the coding gene region (rs24610835 A>C)
[39], the others are in the non - coding gene regions or
the intergenic region. Similarly, in the current study,
statistically significant associations were found between
SNPs in the 3ʹ UTR regions of the CX3CR1 gene and
CHD (p < 0.001 and 0.05). The UTRs play an important
role in the control of gene expression. The 3ʹ UTR regions
are targeted by miRNAs and regulatory molecules and
are involved in the cytoplasmic localization, stability,
and translation efficiency of mRNA. Polymorphisms in
the 3ʹ UTR region can cause diseases by altering these
mechanisms [57].
There are some limitations of this study that should
be considered. First, the sample size is comparatively
small. After the Bonferroni correction for multiple testing,
only one SNP (g.8937121G>A) in Belgian Malinois and,
one SNP - SNP interaction (g.8938599_8938600insCC
and g.8937450A>G) in Labrador Retriever remained
associated with CHD. A small sample size might be a
reason for this observation. Second, only SNPs in the exon
2 and 3ʹ UTR regions of the CX3CR1 gene were analyzed.
Future studies should be designed to large sample sizes for
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various dog breeds and analyze all SNPs on the CX3CR1
gene. After these genetic marker candidates are confirmed
in different dog populations, they can be used in the early
risk assessment of the disease.
In conclusion, a novel deletion, insertion, and six
SNPs were identified in the 3’ UTR region of the CX3CR1
gene by DNA sequencing in the three pure dog breeds.
Using different statistical approaches, susceptibility
polymorphisms for CHD have been identified in the
Labrador Retriever and the Belgian Malinois. Future
studies should focus on the effects of these polymorphisms
on gene expression.
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